Financial Results - Machine Readable Format
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amrutanjan Health Care reported revenue from operations of Rs 50,255 lakh for FY2026, up 11.2% from Rs 45,182 lakh in FY2025. Profit after tax stood at Rs 5,792 lakh, growing 13.9% year-on-year from Rs 5,083 lakh. EPS improved from Rs 17.58 to Rs 20.03 per share. The Board approved a final dividend of Rs 2.90 per share (in addition to Rs 1 interim dividend already paid). Exceptional items of Rs 885.67 lakh were recorded due to a Tamil Nadu lease rent revision (Rs 760.50 lakh) and new labour code impact (Rs 125.17 lakh). New independent director Mr. Ramaswami Krishnan was appointed and the second phase ESOP scheme was approved. The auditor gave an unmodified (clean) opinion.
The company delivered double-digit revenue and profit growth with improving margins, signalling solid operational performance. The one-time exceptional items are non-recurring in nature. Shareholders can expect dividend payouts, though the large exceptional charge may temporarily affect reported profitability.